Lifevantage Corp SEC filings LFVN

Lifevantage Corp has 1,001 filings in SEC EDGAR's recent list, going back to Oct 28, 2009. Its latest annual report, Form ARS, was filed on Sep 18, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 6, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 5, 2026 (bylaw or fiscal year change). The company's fiscal year ends on December 31.

Lifevantage Corp SEC filings
Form Description Filed Period
8-K Current report
Bylaw or fiscal year change
Oct 5, 2026 Sep 29, 2026
ARS Annual report to shareholders Sep 18, 2026 Jun 30, 2026
DEFA14A Additional proxy material Sep 18, 2026 —
DEF 14A Proxy statement Sep 18, 2026 Nov 5, 2026
8-K Current report
Results of operations
Aug 27, 2026 Aug 27, 2026
10-K Annual report Aug 27, 2026 Jun 30, 2026
S-8 Employee stock plan registration Aug 3, 2026 —
8-K Current report
Officer or director change
Aug 3, 2026 Jul 31, 2026
8-K Current report
Results of operations
May 6, 2026 May 6, 2026
10-Q Quarterly report May 6, 2026 Mar 31, 2026
8-K Current report
Officer or director change
Apr 16, 2026 Apr 13, 2026
EFFECT Filing Mar 20, 2026 —
CORRESP Letter to the SEC Mar 18, 2026 —
UPLOAD Letter from the SEC Mar 16, 2026 —
S-3 Shelf registration Mar 10, 2026 —
8-K Current report
Results of operations, Officer or director change
Feb 4, 2026 Jan 30, 2026
10-Q Quarterly report Feb 4, 2026 Dec 31, 2025
8-K Current report
Officer or director change
Dec 9, 2025 Dec 3, 2025
S-8 Employee stock plan registration Nov 14, 2025 —
8-K Current report
Shareholder vote results
Nov 12, 2025 Nov 6, 2025
8-K Current report
Results of operations
Nov 4, 2025 Nov 4, 2025
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
ARS Annual report to shareholders Sep 19, 2025 Jun 30, 2025
DEFA14A Additional proxy material Sep 19, 2025 —
DEF 14A Proxy statement Sep 19, 2025 Sep 19, 2025
8-K Current report
Results of operations
Sep 4, 2025 Sep 4, 2025
10-K Annual report Sep 4, 2025 Jun 30, 2025
8-K Current report
Results of operations
May 6, 2025 May 6, 2025
10-Q Quarterly report May 6, 2025 Mar 31, 2025
8-K Current report
Results of operations
Feb 5, 2025 Feb 5, 2025
10-Q Quarterly report Feb 5, 2025 Dec 31, 2024
S-8 Employee stock plan registration Nov 21, 2024 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Nov 19, 2024 Nov 18, 2024
8-K Current report
Shareholder vote results
Nov 14, 2024 Nov 7, 2024
8-K Current report
Results of operations
Oct 29, 2024 Oct 29, 2024
10-Q Quarterly report Oct 29, 2024 Sep 30, 2024
ARS Annual report to shareholders Sep 20, 2024 Jun 30, 2024
DEFA14A Additional proxy material Sep 20, 2024 —
DEF 14A Proxy statement Sep 20, 2024 Sep 20, 2024
S-8 Employee stock plan registration Aug 28, 2024 —
8-K Current report
Results of operations
Aug 28, 2024 Aug 28, 2024
10-K Annual report Aug 28, 2024 Jun 30, 2024
8-K Current report
Officer or director change
Aug 26, 2024 Aug 26, 2024
8-K Current report
Results of operations
May 2, 2024 May 2, 2024
10-Q Quarterly report May 2, 2024 Mar 31, 2024
8-K Current report
Material agreement, New debt
Apr 16, 2024 Apr 12, 2024
8-K Current report
Material agreement, Officer or director change, Regulation FD disclosure
Feb 15, 2024 Feb 14, 2024
8-K Current report
Results of operations
Jan 30, 2024 Jan 30, 2024
10-Q Quarterly report Jan 30, 2024 Dec 31, 2023
8-K/A Amended current report
Shareholder vote results, Other events
Nov 13, 2023 Nov 6, 2023
8-K Current report
Shareholder vote results
Nov 9, 2023 Nov 6, 2023
8-K Current report
Results of operations
Nov 9, 2023 Nov 9, 2023
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
DFAN14A Filing Nov 2, 2023 —
DFAN14A Filing Oct 30, 2023 —
DEFA14A Additional proxy material Oct 30, 2023 —
UPLOAD Letter from the SEC Oct 27, 2023 —
DFAN14A Filing Oct 27, 2023 —
DFAN14A Filing Oct 26, 2023 —
DEFA14A Additional proxy material Oct 25, 2023 —
DFAN14A Filing Oct 25, 2023 —
DFAN14A Filing Oct 19, 2023 —
DEFA14A Additional proxy material Oct 18, 2023 —
DEFA14A Additional proxy material Oct 16, 2023 —
DEFA14A Additional proxy material Oct 16, 2023 —
DEFA14A Additional proxy material Oct 13, 2023 —
DFAN14A Filing Oct 13, 2023 —
DFAN14A Filing Oct 12, 2023 —
DEFA14A Additional proxy material Oct 10, 2023 —
DEFA14A Additional proxy material Oct 10, 2023 —
DEFA14A Additional proxy material Oct 5, 2023 —
DEFA14A Additional proxy material Oct 2, 2023 —
DFAN14A Filing Sep 26, 2023 —
DEFC14A Filing Sep 25, 2023 —
DEFA14A Additional proxy material Sep 25, 2023 —
ARS Annual report to shareholders Sep 22, 2023 Jun 30, 2023
DEFC14A Filing Sep 22, 2023 —
PREC14A Filing Sep 15, 2023 —
PREC14A Filing Sep 8, 2023 —
8-A12B Filing Aug 31, 2023 —
8-K Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Aug 31, 2023 Aug 30, 2023
8-K Current report
Results of operations
Aug 28, 2023 Aug 28, 2023
10-K Annual report Aug 28, 2023 Jun 30, 2023
DEFA14A Additional proxy material Aug 14, 2023 —
8-K Current report
Other events
Aug 14, 2023 Aug 9, 2023
8-K Current report
Other events
Jun 13, 2023 Jun 12, 2023
8-K Current report
Results of operations
May 4, 2023 May 4, 2023
10-Q Quarterly report May 4, 2023 Mar 31, 2023
8-K Current report
Auditor change
Apr 17, 2023 Apr 13, 2023
EFFECT Filing Apr 6, 2023 —
CORRESP Letter to the SEC Apr 4, 2023 —
UPLOAD Letter from the SEC Apr 4, 2023 —
S-3 Shelf registration Mar 31, 2023 —
8-K Current report
Officer or director change
Mar 23, 2023 Mar 20, 2023
8-K Current report
Auditor change
Feb 16, 2023 Feb 15, 2023
8-K Current report
Results of operations
Feb 2, 2023 Feb 2, 2023
10-Q Quarterly report Feb 2, 2023 Dec 31, 2022
8-K Current report
Other events
Jan 19, 2023 Jan 18, 2023
8-K/A Amended current report
Shareholder vote results
Nov 18, 2022 Nov 10, 2022
8-K Current report
Shareholder vote results
Nov 17, 2022 Nov 10, 2022
8-K Current report
Results of operations
Nov 2, 2022 Nov 2, 2022
10-Q Quarterly report Nov 2, 2022 Sep 30, 2022
DEFA14A Additional proxy material Sep 30, 2022 —
DEF 14A Proxy statement Sep 30, 2022 Sep 16, 2022
8-K Current report
Results of operations
Aug 23, 2022 Aug 23, 2022
10-K Annual report Aug 23, 2022 Jun 30, 2022
8-K Current report
Results of operations
May 3, 2022 May 3, 2022
10-Q Quarterly report May 3, 2022 Mar 31, 2022
8-K Current report
Officer or director change
Mar 11, 2022 Mar 7, 2022
8-K Current report
Officer or director change
Feb 17, 2022 Feb 17, 2022
8-K Current report
Results of operations
Feb 1, 2022 Feb 1, 2022
10-Q Quarterly report Feb 1, 2022 Dec 31, 2021
8-K Current report
Shareholder vote results
Nov 15, 2021 Nov 11, 2021
8-K Current report
Results of operations
Nov 4, 2021 Nov 4, 2021
10-Q Quarterly report Nov 4, 2021 Sep 30, 2021
8-K Current report
Officer or director change
Oct 25, 2021 Oct 25, 2021
DEFA14A Additional proxy material Sep 30, 2021 —
DEF 14A Proxy statement Sep 30, 2021 Sep 17, 2021
8-K Current report
Results of operations
Aug 19, 2021 Aug 19, 2021
10-K Annual report Aug 19, 2021 Jun 30, 2021
8-K Current report
Officer or director change
Aug 16, 2021 Aug 12, 2021
8-K Current report
Officer or director change
May 26, 2021 May 20, 2021
8-K Current report
Results of operations
Apr 29, 2021 Apr 29, 2021
10-Q Quarterly report Apr 29, 2021 Mar 31, 2021
8-K Current report
Results of operations, Officer or director change
Feb 2, 2021 Feb 1, 2021
10-Q Quarterly report Feb 2, 2021 Dec 31, 2020
S-8 Employee stock plan registration Jan 11, 2021 —
8-K Current report
Shareholder vote results
Nov 17, 2020 Nov 12, 2020
DEFA14A Additional proxy material Nov 4, 2020 —
8-K Current report
Results of operations
Nov 3, 2020 Nov 3, 2020
10-Q Quarterly report Nov 3, 2020 Sep 30, 2020
DEFA14A Additional proxy material Sep 30, 2020 —
DEF 14A Proxy statement Sep 30, 2020 Sep 18, 2020
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 8, 2020 Sep 3, 2020
8-K Current report
Results of operations
Aug 18, 2020 Aug 18, 2020
10-K Annual report Aug 18, 2020 Jun 30, 2020
8-K Current report
Results of operations
May 5, 2020 May 5, 2020
10-Q Quarterly report May 5, 2020 Mar 31, 2020
EFFECT Filing Apr 3, 2020 —
CORRESP Letter to the SEC Apr 1, 2020 —
UPLOAD Letter from the SEC Mar 31, 2020 —
S-3 Shelf registration Mar 24, 2020 —
8-K Current report
Results of operations
Jan 28, 2020 Jan 28, 2020
10-Q Quarterly report Jan 28, 2020 Dec 31, 2019
8-K Current report
Results of operations
Jan 14, 2020 Jan 9, 2020
8-K Current report
Shareholder vote results
Dec 10, 2019 Dec 5, 2019
DEFA14A Additional proxy material Nov 26, 2019 —
8-K Current report
Results of operations
Oct 30, 2019 Oct 30, 2019
10-Q Quarterly report Oct 30, 2019 Sep 30, 2019
DEFA14A Additional proxy material Oct 18, 2019 —
DEF 14A Proxy statement Oct 18, 2019 Oct 10, 2019
8-K Current report
Bylaw or fiscal year change
Aug 15, 2019 Aug 9, 2019
8-K Current report
Results of operations
Aug 14, 2019 Aug 14, 2019
10-K Annual report Aug 14, 2019 Jun 30, 2019
8-K Current report
Officer or director change
May 8, 2019 May 8, 2019
8-K Current report
Results of operations
May 1, 2019 May 1, 2019
10-Q Quarterly report May 1, 2019 Mar 31, 2019
8-K Current report
Material agreement, Results of operations, New debt, Other events
Feb 4, 2019 Feb 4, 2019
10-Q Quarterly report Feb 4, 2019 Dec 31, 2018
8-K Current report
Results of operations, Officer or director change
Jan 10, 2019 Jan 10, 2019
S-8 Employee stock plan registration Nov 30, 2018 —
8-K Current report
Officer or director change, Shareholder vote results
Nov 19, 2018 Nov 15, 2018
8-K Current report
Results of operations
Nov 1, 2018 Nov 1, 2018
10-Q Quarterly report Nov 1, 2018 Sep 30, 2018
DEFA14A Additional proxy material Sep 28, 2018 —
DEF 14A Proxy statement Sep 28, 2018 Sep 28, 2018
8-K Current report
Results of operations
Aug 15, 2018 Aug 15, 2018
10-K Annual report Aug 15, 2018 Jun 30, 2018
8-K Current report
Other events
Jul 31, 2018 Jul 26, 2018
8-K Current report
Results of operations
May 9, 2018 May 9, 2018
10-Q Quarterly report May 9, 2018 Mar 31, 2018
8-A12B/A Filing Mar 13, 2018 —
8-K Current report
Change to shareholder rights, Officer or director change, Bylaw or fiscal year change
Mar 13, 2018 Mar 9, 2018
8-K Current report
Results of operations
Feb 7, 2018 Feb 7, 2018
10-Q Quarterly report Feb 7, 2018 Dec 31, 2017
8-K Current report
Officer or director change, Shareholder vote results
Feb 7, 2018 Feb 7, 2018
DEFA14A Additional proxy material Jan 26, 2018 —
DEFA14A Additional proxy material Jan 23, 2018 —
8-K Current report
Other events
Jan 8, 2018 Jan 8, 2018
DEFA14A Additional proxy material Dec 20, 2017 —
DEF 14A Proxy statement Dec 20, 2017 Dec 20, 2017
PRE 14A Preliminary proxy statement Nov 28, 2017 Nov 28, 2017
8-K Current report
Other events
Nov 27, 2017 Nov 27, 2017
8-K Current report
Results of operations
Nov 8, 2017 Nov 8, 2017
10-Q Quarterly report Nov 8, 2017 Sep 30, 2017
8-K Current report
Other events
Oct 23, 2017 Oct 23, 2017
8-K Current report
Results of operations
Sep 7, 2017 Sep 7, 2017
10-K Annual report Sep 7, 2017 Jun 30, 2017
8-K Current report
Results of operations
May 10, 2017 May 10, 2017
10-Q Quarterly report May 10, 2017 Mar 31, 2017
S-8 Employee stock plan registration Mar 27, 2017 —
8-K Current report
Officer or director change
Mar 13, 2017 Mar 13, 2017
8-K Current report
Officer or director change
Mar 9, 2017 Mar 9, 2017
8-K Current report
Shareholder vote results
Feb 23, 2017 Feb 23, 2017
8-K Current report
Results of operations
Feb 8, 2017 Feb 8, 2017
10-Q Quarterly report Feb 8, 2017 Dec 31, 2016
DEFA14A Additional proxy material Feb 3, 2017 —
8-K Current report
Material agreement, Officer or director change, Other events
Jan 18, 2017 Jan 18, 2017
DEF 14A Proxy statement Jan 4, 2017 Jan 4, 2017
8-K Current report
Other events
Dec 16, 2016 Dec 16, 2016

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
LFVN (Nasdaq)
Fiscal year ends
December 31
Headquarters
Lehi, UT
SEC filer status
Accelerated filer, Smaller reporting company
SEC CIK
849146
Former names
LIFELINE THERAPEUTICS, INC. (until Dec 6, 2006); YAAK RIVER RESOURCES INC (until Sep 28, 2004)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.